Delivery Order SPE2DB22D9244-SPE2DB25FZS14
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a firm fixed-price delivery order with no set-aside designation applied. This award falls under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a direct pharmaceutical supply transaction under DLA's established procurement framework. The contract carries no...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units) under firm fixed-price terms. The contract, valued at $12,146.79 with an ultimate completion date of September 22, 2025, was awarded on September 19, 2025, with no set-aside designation applied. This delivery order falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $12,146.79 delivery order to DMS Pharmaceutical Group Inc. on April 24, 2025, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price contract represents a standard pharmaceutical delivery under DMS's larger indefinite delivery contract vehicle with DLA. The award carries no set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis. Performance will be completed by April 25, 2025, with...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, valued at $12,115.65, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $94,761.88 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, which runs through March 11, 2024, is for the delivery of 4,563,904,762 units of the pharmaceutical drug Jakafi 5 mg tablets. This delivery order is part of a larger indefinite delivery contract, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999 through the...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,146.79, was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing as a small business in...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc. on September 15, 2025, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, valued at $24,179.58, represents a single purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program. The contract requires delivery to Park Ridge, Illinois, with an ultimate completion date of September 16, 2025. No set-aside...
- SPE2DB22D9244Indefinite Delivery Contract
- SPE2DB22D9244-SPE2DB25FZS14Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract, effective May 30, 2025, carries a ceiling value of $12,146.79 and represents a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. This award was made without set-aside designation, demonstrating the contractor's competitive positioning in the federal pharmaceutical procurement market. The place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026 that authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group maintains a robust portfolio of pharmaceutical product deliveries to the Department of Defense healthcare system, encompassing branded and generic prescription drugs, biologics, and medical consumables. The delivery of Jakafi, an oral medication, supports the DLA's objective to maintain comprehensive pharmaceutical inventory for military medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 5/30/25 |